| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) CHF (HEDGED) | RVI BIOTECNOLOGÍA | 112,532244 | 31/07/2026 | 6,18% | 9,59% | ** |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 114,350000 | 31/07/2026 | 7,43% | 12,96% | ** |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) GBP (HEDGED) | RVI BIOTECNOLOGÍA | 145,957253 | 31/07/2026 | 10,58% | 18,50% | ** |
| JPM THEMATICS-GENETIC THERAPIES C2 (ACC) USD | RVI BIOTECNOLOGÍA | 108,289073 | 31/07/2026 | 10,27% | 12,81% | ** |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) CHF (HEDGED) | RVI BIOTECNOLOGÍA | 111,349957 | 31/07/2026 | 6,19% | 8,58% | ** |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 113,130000 | 31/07/2026 | 7,43% | 11,93% | ** |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) GBP (HEDGED) | RVI BIOTECNOLOGÍA | 144,297851 | 31/07/2026 | 10,57% | 17,35% | ** |
| JPM THEMATICS-GENETIC THERAPIES C2 (DIST) USD | RVI BIOTECNOLOGÍA | 107,104919 | 31/07/2026 | 10,27% | 11,75% | ** |
| JPM THEMATICS-GENETIC THERAPIES C (ACC) EUR (HEDGED) | RVI BIOTECNOLOGÍA | 92,860000 | 31/07/2026 | 7,35% | 12,65% | ** |
| JPM THEMATICS-GENETIC THERAPIES C (ACC) USD | RVI BIOTECNOLOGÍA | 87,653461 | 31/07/2026 | 10,19% | 12,51% | ** |
